Lataa...
Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report
Context. Many phosphoinositide-3-kinase (PI3K) inhibitors are under trial for cancer treatment. We present a patient taking taselisib who developed ketoacidosis within 1 week of starting canagliflozin. Case Description. A 69-year-old female patient with no previous history of diabetes mellitus was e...
Tallennettuna:
| Julkaisussa: | J Investig Med High Impact Case Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571767/ https://ncbi.nlm.nih.gov/pubmed/28856166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709617725351 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|